These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30185529)

  • 21. Factors influencing primary care physicians' decision to order prostate-specific antigen (PSA) test for men without prostate cancer.
    Hayat Roshanai A; Nordin K; Berglund G
    Acta Oncol; 2013 Nov; 52(8):1602-8. PubMed ID: 23421929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
    Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
    BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GPs views and understanding of PSA testing, screening and early detection; survey.
    Sutton J; Melia J; Kirby M; Graffy J; Moss S
    Int J Clin Pract; 2016 May; 70(5):389-95. PubMed ID: 27121158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of prostatic specific antigen in primary care (PSA)].
    Panach-Navarrete J; Gironés-Montagud A; Sánchez-Cano E; Doménech-Pérez C; Martínez-Jabaloyas JM
    Semergen; 2017 Apr; 43(3):189-195. PubMed ID: 27344583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical practice and new technology: prostate-specific antigen (PSA).
    Stuart ME; Handley MA; Thompson RS; Conger M; Timlin D
    HMO Pract; 1992 Dec; 6(4):5-11. PubMed ID: 10123759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate cancer screening: a survey of attitudes and practices among Finnish physicians in 1999 and 2007.
    Pogodin-Hannolainen D; Juusela H; Tammela TL; Ruutu M; Aro J; Määttänen L; Auvinen A
    J Med Screen; 2011; 18(1):46-9. PubMed ID: 21536817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive values of GPs' suspicion of serious disease are high enough to warrant subsequent investigation.
    Holtedahl K
    Evid Based Med; 2014 Dec; 19(6):232. PubMed ID: 25139889
    [No Abstract]   [Full Text] [Related]  

  • 28. Falling through the cracks: New Zealand prostate cancer survivors' experiences and views regarding PSA testing.
    Patel A; MacLeod R; Masters J; Keogh J
    N Z Med J; 2014 Aug; 127(1400):106-9. PubMed ID: 25145373
    [No Abstract]   [Full Text] [Related]  

  • 29. PSA test not recommended by Canadian Task Force.
    Tanday S
    Lancet Oncol; 2014 Dec; 15(13):e589. PubMed ID: 25499287
    [No Abstract]   [Full Text] [Related]  

  • 30. Liaise with pathologists to refine understanding of the prostate-specific antigen test.
    Sikaris KA; Ross BA; Khong TY
    Med J Aust; 2013 Nov; 199(10):656, 658. PubMed ID: 24237087
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of the 2012 United States Preventive Services Task Force statement on prostate-specific antigen screening: analysis of urologic and primary care practices.
    Perez TY; Danzig MR; Ghandour RA; Badani KK; Benson MC; McKiernan JM
    Urology; 2015 Jan; 85(1):85-9. PubMed ID: 25440819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Punishing Physicians for PSA Screening.
    Gomella LG
    Can J Urol; 2015 Dec; 22(6):8042. PubMed ID: 26688130
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of physician recommendation on prostate-specific antigen screening.
    Pucheril D; Dalela D; Sammon J; Sood A; Sun M; Trinh QD; Menon M; Abdollah F
    Urol Oncol; 2015 Oct; 33(10):424.e1-7. PubMed ID: 26206103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer screening.
    Cook ED; Nelson AC
    Curr Oncol Rep; 2011 Feb; 13(1):57-62. PubMed ID: 20981510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of lowering the prostate-specific antigen normal cutoff on referral rates to urology.
    Shenker BS; Stern J
    J Am Board Fam Med; 2012; 25(6):927-9. PubMed ID: 23136335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Revisiting Prostate Cancer Screening Practices Among Vermont Primary Care Physicians.
    Donnelly L; Sternberg KM; Ashikaga T; Plante MK; Perrapato SD
    J Community Health; 2018 Feb; 43(1):33-37. PubMed ID: 28620736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for Prostate Cancer: Recommendation Statement.
    Am Fam Physician; 2018 Oct; 98(8):Online. PubMed ID: 30277733
    [No Abstract]   [Full Text] [Related]  

  • 38. Risks of PSA screening now better understood.
    Peres J
    J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
    [No Abstract]   [Full Text] [Related]  

  • 39. The patient perspective on a first raised PSA test.
    Brown C; Hodgson F; Obertova Z; Holmes M; Lawrenson R
    J Prim Health Care; 2015 Sep; 7(3):213-20. PubMed ID: 26437045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study.
    Walsh AL; Considine SW; Thomas AZ; Lynch TH; Manecksha RP
    Br J Gen Pract; 2014 Dec; 64(629):e783-7. PubMed ID: 25452543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.